ClinicalTrials.Veeva

Menu

Snoring Intervention Via Elevoplasty in a Non-surgical Clinical Environment (SILENCE)

Z

Zelegent

Status

Completed

Conditions

Snoring

Treatments

Device: Elevoplasty

Study type

Interventional

Funder types

Industry

Identifiers

NCT03083106
GCP002-001

Details and patient eligibility

About

Single Group Compared to Baseline, Non-Randomized, Multi-Center, Prospective Safety & Efficacy Study

Full description

Evaluate the safety and efficacy of the Zelegent, Inc. Elevo™ Kit Snoring Intervention Device (a minimally invasive, barbed, absorbable suture implant) in the reduction of simple snoring through subjective evaluation of snoring and objective snoring sound analysis.

The Zelegent, Inc. Elevo™ Kit Snoring Intervention Device is intended to reduce or eliminate simple snoring in the target patient population via minimally invasive implantation of specialized barbed, absorbable sutures in the soft palate for the purpose of stiffening by way of shortening and lifting the soft palate thereby addressing the root cause of snoring.

Enrollment

52 patients

Sex

All

Ages

22+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 22 years (no maximum age)
  • Has consistent Bed/Sleep Partner willing to provide Co-Participant Informed Consent
  • Apnea Hypopnea Index (AHI) of < 15 verified by polysomnogram (PSG) or by SNAP® Diagnostics Home Sleep Study (HSS)
  • Has basic computer literacy (e.g., email) and home internet access or smartphone
  • Chronic, simple snoring (verified by Bed/Sleep Partner)
  • No prior surgical treatment for snoring
  • Bed/Sleep Partner willing and capable of providing Informed Consent

Exclusion criteria

  • Age < 22 years
  • Has no consistent Bed/Sleep Partner
  • Apnea Hypopnea Index (AHI) > 15 indicative of Obstructive Sleep Apnea
  • Intermittent or occasional snoring
  • Body Mass Index (BMI) > 32 kg/m2
  • Modified Mallampati 3 or 4
  • Tonsil Grade 3 or 4+
  • Significant nasal obstruction
  • Previous palatal surgery
  • Current cigarette smoker
  • Known history of coronary artery disease or stroke
  • Chronic obstructive pulmonary disease (COPD)
  • Diabetes (Type I or Type II) non-controlled by medical management
  • Major depression or non-controlled psychiatric illness
  • Drug or alcohol abuse
  • Untreated or poorly controlled hypertension
  • Anticoagulation therapy
  • History of bleeding or clotting disorder
  • Pregnant Female

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

52 participants in 1 patient group

Elevoplasty treatment
Other group
Description:
Single Group Compared to Baseline, Non-Randomized, Multi-Center, Prospective
Treatment:
Device: Elevoplasty

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems